Radiofrequency Ablation of Barrett’s Esophagus: Let’s Not Get Ahead of Ourselves
- Gary W. Falk
- … show all 1 hide
Radiofrequency ablation (RFA) represents an exciting advance for the treatment of Barrett’s esophagus. The research work on RFA performed to date has involved a stepwise progression from initial animal studies to human studies prior to esophagectomy, human dosimetry studies, single-center studies, multicenter nonrandomized studies, and ultimately multicenter, randomized, controlled trials [1–5]. This process also led to modifications in the RFA technique and to the development of the focal ablation device. Regardless of the eventual role of RFA, this series of studies illustrates the appropriate steps in the development and application of future ablative technologies. However, this approach may be limited to certain subsets of patients by the high costs required for the development and widespread application of new endoscopic therapeutic technologies. Nevertheless, the impact of this development paradigm in the evolution of RFA is obvious, and both the investigators and the manufacture ...
- Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc. 2004;60:1002–1010. CrossRef
- Dunkin BJ, Martinez J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc. 2006;20:125–130. CrossRef
- Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195. CrossRef
- Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867–876. CrossRef
- Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–2288. CrossRef
- Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett’s esophagus. Dig Dis Sci. 2010 Apr 20 [Epub ahead of print].
- Wang KK, Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797. CrossRef
- Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–29. CrossRef
- van Vilsteren FGI, Pouw RE, Seewald S, et al. A multi-center randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer. Gastrointest Endosc. 2009;69:AB133. CrossRef
- Ofman JJ, Lewin K, Ramers C, Ippoliti A, Lieberman D, Weinstein W. The economic impact of the diagnosis of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2000;95:2946–2952. CrossRef
- Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett’s esophagus Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol. 2003;98:1931–1939. CrossRef
- Wani S, Puli SR, Shaheen NJ, et al. Esophageal adenocarcinoma in Barrett’s esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009;104:502–513. CrossRef
- Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol. 2000;95:3383–3387. CrossRef
- Srivastava A, Hornick JL, Li X, et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett’s esophagus. Am J Gastroenterol. 2007;102:483–493. CrossRef
- Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–244. CrossRef
- Moayyedi P, Burch N, Akhtar-Danesh N, et al. Mortality rates in patients with Barrett’s oesophagus. Aliment Pharmacol Ther. 2008;27:316–320.
- Shaheen NJ, Green B, Medapalli RK, et al. The perception of cancer risk in patients with prevalent Barrett’s esophagus enrolled in an endoscopic surveillance program. Gastroenterology. 2005;129:429–436.
- Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation of Barrett’s esophagus: five-year durability outcomes from a prospective multi-center study trial. Gastrointest Endosc. 2010;71:AB117. CrossRef
- Shaheen NJ, DE Fleischer, Eisen GM, et al. Durability of epithelial reversion after radiofrequency ablation: follow-up of the AIM Dysplasia Trial. Gastroenterology. 2010;138:S16. CrossRef
- Gupta N, Mathur SC, Singh V, et al. Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for post-ablation surveillance in Barrett’s esophagus (BE)? Gastroenterology. 2010;138:S17.
- Weston AP, Sharma P, Banerjee S, Mitreva D, Mathur S. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett’s esophagus ablation. Gastrointest Endosc. 2005;61:515–521. CrossRef
- Sampliner RE, Camargo E, Prasad AR. Association of ablation of Barrett’s esophagus with high-grade dysplasia and adenocarcinoma of the gastric cardia. Dis Esophagus. 2006;19:277–279. CrossRef
- Fass R, Garewal HS, Hayden CW, Ramsey L, Sampliner RE. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett’s esophagus. Gastrointest Endosc. 2001;53:711–716. CrossRef
- Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26–33. CrossRef
- Radiofrequency Ablation of Barrett’s Esophagus: Let’s Not Get Ahead of Ourselves
Digestive Diseases and Sciences
Volume 55, Issue 7 , pp 1811-1814
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Gary W. Falk (1)
- Author Affiliations
- 1. Hospital of the University of Pennsylvania, Division of Gastroenterology, University of Pennsylvania School of Medicine, 3 Ravdin, 3400 Spruce Street, Philadelphia, PA, 19104, USA